- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02746484
ABILITY - TelerehABILITation: TechnologY-enhanced Multi-domain at Home Continuum of Care Program
ABILITY - TelerehABILITation. TechnologY-enhanced Multi-domain at Home Continuum of Care Program for People With Cognitive Impairment.
The Ability research project, funded in Italy within the Smart Cities and Smart Communities funding program (MInistry of University and Research, Operational Regional Programme, Lombardy, Axis 1, Operational Regional Programme - European Funding for Regional Development 2007-2013), aims at developing and testing the efficacy and the impact of a Personal Smart Health Community able to provide innovative trajectories for people with cognitive impairment, putting them at the core of a continuous and intertwining treatment and support from both formal (e.g. physicians) and informal (e.g. near relatives) caregivers, with special focus on home-based care.
Within this framework of the Ability project the investigators test the efficacy of the home-based motor-cognitive rehabilitation program delivered with two different approaches: the Ability platform versus the usual care program
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- diagnosed as mild AD or MCI due to AD (Albert et al, 2011) according to DSM 5 diagnostic criteria (American Psychiatric Association, 2013);
- MMSE score >18
- school attendance (≥ 3 years).
Exclusion Criteria:
- dysmetria;
- serious deficits in visual acuity, acoustic perception, and in routine communication skills.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Ability platform program
Multi-domain at home rehabilitation program delivered through the Ability platform.
|
The Ability program is an at home participant-tailored and technology-enhanced platform a) delivering tablet-based intensive (five days/a week for six weeks) motor and cognitive activities; b) monitoring from remote vital and physical health parameters (i.e., weight, Heart Rate, O2 saturation, daily steps, sleep activity).
|
|
Aktiv komparator: Usual care program
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
|
Usual care at home program (paper and pencil cognitive activities; promotion of physical activity according to healthcare professional's advice)
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
activities of daily living
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Activities of Daily Living Inventory (ADCS/ADL)
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
behavioral symptoms
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Neuropsychiatric Inventory (NPI) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
cognitive domain (long-term memory)
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Free and Cued Selective Recall Test (FCSRT) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
cognitive domain (language)
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Fluency score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
cognitive domain (frontal-executive functions)
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Trail Making Test (TMT) score
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
quality of life
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Dementia Quality of Life (D-QoL) Instrument
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
coping strategies
Tidsramme: change from baseline after 8 weeks (aMCI/AD subjects)
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 8 weeks (aMCI/AD subjects)
|
|
global cognitive level
Tidsramme: change from baseline after 12 months (aMCI/AD subjects)
|
Montreal Cognitive Asssessment (MoCA) score
|
change from baseline after 12 months (aMCI/AD subjects)
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
activities of daily living
Tidsramme: change from baseline after 12 months (aMCI/AD subjects)
|
Activities of Daily Living Inventory (ADCS/ADL)
|
change from baseline after 12 months (aMCI/AD subjects)
|
|
conversion rate MCI versus AD
Tidsramme: change from baseline after 12 months (aMCI subjects)
|
conversion rate score
|
change from baseline after 12 months (aMCI subjects)
|
|
cognitive domain - long term memory
Tidsramme: change from baseline after 12 months (aMCI/AD subjects)
|
Free and Cued Selective Recall Test (FCSRT) score
|
change from baseline after 12 months (aMCI/AD subjects)
|
|
cognitive domain - language
Tidsramme: change from baseline after 12 months (aMCI/AD subjects)
|
Fluency score
|
change from baseline after 12 months (aMCI/AD subjects)
|
|
cognitive domain - frontal executive functions
Tidsramme: change from baseline after 12 months
|
Trail Making Test (TMT) score
|
change from baseline after 12 months
|
|
quality of life
Tidsramme: change from baseline after 12 months
|
Dementia Quality of Life (D-QoL) Instrument
|
change from baseline after 12 months
|
|
coping strategies
Tidsramme: change from baseline after 12 months
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 12 months
|
|
caregiver quality of life
Tidsramme: change from baseline after 8 weeks and after 12 months
|
Psychological Well-Being (PWB) scale
|
change from baseline after 8 weeks and after 12 months
|
|
caregiver coping strategies
Tidsramme: change from baseline after 8 weeks and after 12 months
|
Coping Orientation for Problems Experienced - Brief Version (Brief COPE)
|
change from baseline after 8 weeks and after 12 months
|
|
caregiver burden
Tidsramme: change from baseline after 8 weeks and after 12 months
|
Caregiver Burden Inventory (CBI)
|
change from baseline after 8 weeks and after 12 months
|
|
caregiver affect
Tidsramme: change from baseline after 8 weeks and after 12 months
|
Positive and Negative Affect Schedule (PANAS)
|
change from baseline after 8 weeks and after 12 months
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Publikationer og nyttige links
Generelle publikationer
- Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008. Epub 2011 Apr 21.
- Realdon O, Rossetto F, Nalin M, Baroni I, Cabinio M, Fioravanti R, Saibene FL, Alberoni M, Mantovani F, Romano M, Nemni R, Baglio F. Technology-enhanced multi-domain at home continuum of care program with respect to usual care for people with cognitive impairment: the Ability-TelerehABILITation study protocol for a randomized controlled trial. BMC Psychiatry. 2016 Nov 25;16(1):425. doi: 10.1186/s12888-016-1132-y.
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- FdG_AD_02
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Demens
-
ACADIA Pharmaceuticals Inc.RekrutteringLewy Body Dementia PsychosisForenede Stater, Tjekkiet, Serbien, Frankrig, Bulgarien, Italien
-
ACADIA Pharmaceuticals Inc.Tilmelding efter invitationLewy Body Dementia PsychosisForenede Stater, Tjekkiet, Bulgarien
Kliniske forsøg med Ability platform program
-
The University of QueenslandRestorative Outcomes Australia; Department of Education, Queensland; Queensland... og andre samarbejdspartnereUkendtAntisocial adfærd | Skolegang | VelfærdsafhængighedAustralien
-
Massachusetts General HospitalNational Institute on Aging (NIA)Aktiv, ikke rekrutterende
-
Ufuk UniversityUkendt
-
University of HuddersfieldAfsluttetAttention Deficit Hyperactivity DisorderDet Forenede Kongerige
-
Universidade Federal de PernambucoUkendtDyrke motion | NyretransplantationBrasilien
-
Stanford UniversityUniversity of MichiganIkke rekrutterer endnuGenetisk disposition | Familie medlemmer
-
Defence Primary Health Care, UKUniversity of BirminghamAktiv, ikke rekrutterendeTandtab | Tandimplantat mislykkedes | ImplantatkomplikationDet Forenede Kongerige
-
University of California, Los AngelesNational Institute on Aging (NIA); BioSensicsAktiv, ikke rekrutterendeKognitiv svækkelse | Demens | Mild kognitiv svækkelse | HukommelsestabForenede Stater
-
Aristotle University Of ThessalonikiRegion Stockholm; Hospital Universitario La Fe; University of GlasgowAfsluttet
-
Universidade Estadual do Norte do ParanaConselho Nacional de Desenvolvimento Científico e TecnológicoAfsluttetLivskvalitet | Fysisk funktionel ydeevne | Knogletæthed | Utilsigtet fald | MusklerBrasilien